|
1
|
Sherris J, Herdman C and Elias C: Cervical
cancer in the developing world. West J Med. 175:231–233. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang P, Xi J and Liu S: MiR-139-3p
induces cell apoptosis and inhibits metastasis of cervical cancer
by targeting NOB1. Biomed Pharmacother. 83:850–856. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu J, Zhang W, Lv Q and Zhu D:
Overexpression of miR-21 promotes the proliferation and migration
of cervical cancer cells via the inhibition of PTEN. Oncol Rep.
33:3108–3116. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Babashah S, Bakhshinejad B, Birgani MT,
Pakravan K and Cho WC: Regulation of microRNAs by phytochemicals: A
promising strategy for cancer chemoprevention. Curr Cancer Drug
Targets. Jun 23–2017.(Epub ahead of print). PubMed/NCBI
|
|
5
|
Zhang H, Li T, Zheng L and Huang X:
Biomarker MicroRNAs for diagnosis of oral squamous cell carcinoma
identified based on gene expression data and MicroRNA-mRNA network
analysis. Comput Math Methods Med. 2017:98030182017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Makiguchi T, Yamada M, Yoshioka Y, Sugiura
H, Koarai A, Chiba S, Fujino N, Tojo Y, Ota C, Kubo H, et al: Serum
extracellular vesicular miR-21-5p is a predictor of the prognosis
in idiopathic pulmonary fibrosis. Respir Res. 17:1102016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han Y, Xu GX, Lu H, Yu DH, Ren Y, Wang L,
Huang XH, Hou WJ, Wei ZH, Chen YP, et al: Dysregulation of miRNA-21
and their potential as biomarkers for the diagnosis of cervical
cancer. Int J Clin Exp Pathol. 8:7131–7139. 2015.PubMed/NCBI
|
|
8
|
Kowalczyk AE, Krazinski BE, Godlewski J,
Grzegrzolka J, Kiewisz J, Kwiatkowski P, Sliwinska-Jewsiewicka A,
Dziegiel P and Kmiec Z: SATB1 is down-regulated in clear cell renal
cell carcinoma and correlates with miR-21-5p overexpression and
poor prognosis. Cancer Genomics Proteomics. 13:209–217.
2016.PubMed/NCBI
|
|
9
|
Zheng G, Li N, Jia X, Peng C, Luo L, Deng
Y, Yin J, Song Y, Liu H, Lu M, et al: MYCN-mediated miR-21
overexpression enhances chemo-resistance via targeting CADM1 in
tongue cancer. J Mol Med (Berl). 94:1129–1141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lopes-Ramos CM, Habr-Gama A, Quevedo Bde
S, Felício NM, Bettoni F, Koyama FC, Asprino PF, Galante PA,
Gama-Rodrigues J, Camargo AA, et al: Overexpression of miR-21-5p as
a predictive marker for complete tumor regression to neoadjuvant
chemoradiotherapy in rectal cancer patients. BMC Med Genomics.
7:682014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park SK, Park YS, Ahn JY, Do EJ, Kim D,
Kim JE, Jung K, Byeon JS, Ye BD, Yang DH, et al: MiR 21–5p as a
predictor of recurrence in young gastric cancer patients. J
Gastroenterol Hepatol. 31:1429–1435. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bellissimo T, Russo E, Ganci F, Vico C,
Sacconi A, Longo F, Vitolo D, Anile M, Disio D, Marino M, et al:
Circulating miR-21-5p and miR-148a-3p as emerging non-invasive
biomarkers in thymic epithelial tumors. Cancer Biol Ther. 17:79–82.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Yao T, Wang Y, Yu J, Liu Y and
Lin Z: Long noncoding RNA MEG3 is downregulated in cervical cancer
and affects cell proliferation and apoptosis by regulating miR-21.
Cancer Biol Ther. 17:104–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim WY and Kaelin WG: Role of VHL gene
mutation in human cancer. J Clin Oncol. 22:4991–5004. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kaelin WG Jr: The von Hippel-Lindau tumor
suppressor gene and kidney cancer. Clin Cancer Res. 10:6290s–6295s.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaelin WG: The von Hippel-Lindau tumor
suppressor protein: Roles in cancer and oxygen sensing. Cold Spring
Harb Symp Quant Biol. 70:159–166. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Neal CS, Michael MZ, Rawlings LH, Van der
Hoek MB and Gleadle JM: The VHL-dependent regulation of microRNAs
in renal cancer. BMC Med. 8:642010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu X, Cai X, Hu B, Mei Z, Zhang D, Ouyang
G, Wang J, Zhang W and Xiao W: Forkhead transcription factor 3a
(FOXO3a) modulates hypoxia signaling via up-regulation of von
Hippel-Lindau gene (VHL). J Biol Chem. 291:25692–25705. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Welford SM, Dorie MJ, Li X, Haase VH and
Giaccia AJ: Renal oxygenation suppresses VHL loss-induced
senescence that is caused by increased sensitivity to oxidative
stress. Mol Cell Biol. 30:4595–4603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chetram MA, Bethea DA, Odero-Marah VA,
Don-Salu-Hewage AS, Jones KJ and Hinton CV: ROS-mediated activation
of AKT induces apoptosis via pVHL in prostate cancer cells. Mol
Cell Biochem. 376:63–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
LaGory EL, Wu C, Taniguchi CM, Ding CC,
Chi JT, von Eyben R, Scott DA, Richardson AD and Giaccia AJ:
Suppression of PGC-1α is critical for reprogramming oxidative
metabolism in renal cell carcinoma. Cell Rep. 12:116–127. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Damjanovic SS, Ilic BB, Beleslin Cokic BB,
Antic JA, Bankovic JZ, Milicevic IT, Rodic GS, Ilic DS, Todorovic
VN, Puskas N and Tulic CD: Tuberous sclerosis complex protein 1
expression is affected by VHL Gene alterations and HIF-1α
production in sporadic clear-cell renal cell carcinoma. Exp Mol
Pathol. 101:323–331. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiao B, Zhou X, Ye M, Lv S, Wu M, Liao C,
Han L, Kang C and Zhu X: MicroRNA566 modulates vascular endothelial
growth factor by targeting Von HippelLandau in human glioblastoma
in vitro and in vivo. Mol Med Rep. 13:379–385. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cao Y, Zhang J, Xiong D, Wang D, Wu T,
Huang A and Tang H: Hsa-miR-331-3p inhibits VHL expression by
directly targeting its mRNA 3′-UTR in HCC cell lines. Acta Biochim
Pol. 62:77–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu N, Xia WY, Liu SS, Chen HY, Sun L, Liu
MY, Li LF, Lu HM, Fu YJ, Wang P, et al: MicroRNA-101 targets von
Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated
apoptosis and cell cycle arrest in normoxia condition. Sci Rep.
6:204892016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma X, Shen D, Li H, Zhang Y, Lv X, Huang
Q, Gao Y, Li X, Gu L, Xiu S, et al: MicroRNA-185 inhibits cell
proliferation and induces cell apoptosis by targeting VEGFA
directly in von Hippel-Lindau-inactivated clear cell renal cell
carcinoma. Urol Oncol. 33:169.e1–11. 2015. View Article : Google Scholar
|
